RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$254.25

Market cap

$36.68B

P/E Ratio

24.28

Dividend/share

$2.46

EPS

$10.47

Enterprise value

$36.03B

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 91

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies ...

Highlights
The gross profit has grown by 13% YoY
The company's revenue rose by 10% YoY and by 2.1% QoQ
The price to earnings (P/E) is 26% lower than the 5-year quarterly average of 32.7 but 5% higher than the last 4 quarters average of 23.0
Resmed's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.resmed.com
Peers: MDT TMO ELMD INGN

Key stats

What are the main financial stats of RMD

RMD stock price

How has the Resmed stock price performed over time
Intraday
0.47%
1 week
6.39%
1 month
14.37%
1 year
-4.15%
YTD
5.55%
QTD
14.99%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$5.65B
Gross profit
$3.45B
Operating income
$1.89B
Net income
$1.52B
Gross margin
61.1%
Net margin
26.9%
The gross profit has grown by 13% YoY
RMD's operating income is up by 12% YoY
The company's revenue rose by 10% YoY and by 2.1% QoQ
RMD's net income is up by 9% YoY

Price vs fundamentals

How does RMD's price correlate with its fundamentals

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
24.28
P/B
5.6
P/S
6.54
EV/EBIT
18.77
EV/EBITDA
16.65
EV/Sales
6.37
The price to earnings (P/E) is 26% lower than the 5-year quarterly average of 32.7 but 5% higher than the last 4 quarters average of 23.0
The EPS has increased by 10% YoY
RMD's P/B is 22% below its 5-year quarterly average of 7.1 but 3.1% above its last 4 quarters average of 5.4
RMD's equity is up by 10% year-on-year
The P/S is 11% lower than the 5-year quarterly average of 7.3 but 3.3% higher than the last 4 quarters average of 6.3
The company's revenue rose by 10% YoY and by 2.1% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital rose by 17% YoY
Resmed's ROE has decreased by 6% YoY and by 2% from the previous quarter
The ROA has decreased by 5% YoY and by 2.2% from the previous quarter
The ROS has increased by 4.3% YoY

Dividends

What is RMD's dividend history
Dividend details
DPS
$2.46
Dividend yield
0.97%
Payout ratio
23.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Resmed financials performed over time
Resmed's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
The current ratio has contracted by 10% YoY but it has grown by 3% from the previous quarter
Resmed's debt is 87% lower than its equity
RMD's equity is up by 10% year-on-year
Resmed's debt to equity has decreased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.